Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
‘It is very hard for us’ : Maccabi Tel Aviv aim to give absent fans reason to smile
5/11/2025
Jack DeJohnette obituary
5/11/2025
The Sun publisher agrees to pay Christopher Jefferies ‘substantial damages’
5/11/2025
Garnacho spares Chelsea shock Champions League loss at Qarabag
5/11/2025
CD Rose awarded the 2025 Goldsmiths prize
5/11/2025
Disgraced former king of Spain’s memoir details ‘enormous respect’ for Franco
5/11/2025